NRx Pharmaceuticals, Inc. (NRXP) Social Stream
NRX PHARMACEUTICALS INC (NRXP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NRX PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-30 | 1 | $2 | $2 | $2 | $0.251 | 696.81% |
| 2023-02-02 | 2 | $4 | $2 | $3 | $0.251 | 1095.22% |
| 2023-03-17 | 3 | $4 | $2 | $3 | $0.251 | 1095.22% |
| 2023-05-25 | 3 | $9 | $2 | $5 | $0.251 | 1892.03% |
| 2023-08-07 | 3 | $4 | $0.35 | $2.116 | $0.251 | 743.03% |
| 2023-08-15 | 3 | $4 | $0.33 | $2.11 | $0.251 | 740.64% |
| 2023-09-07 | 3 | $4 | $2 | $2.666 | $0.251 | 962.15% |
The Trend in the Analyst Price Target
Over the past 14 months, NRXP's average price target has gone up $0.67.
NRXP reports an average of 446.79% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-09 | 2 | 4 | 2.00 | 3.000 | 0.870 | 244.83% |
| 2022-11-15 | 2 | 4 | 2.00 | 3.000 | 0.931 | 222.23% |
| 2023-02-02 | 3 | 4 | 2.00 | 3.000 | 1.250 | 140% |
| 2023-05-25 | 3 | 9 | 2.00 | 5.000 | 0.677 | 638.55% |
| 2023-08-07 | 3 | 4 | 0.35 | 2.116 | 0.327 | 547.09% |
NRXP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 2 | 1 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 30 weeks, NRXP's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how NRX PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is higher than 11.63% of that group.
- NRX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 769.09% of all US stocks.
- NRX PHARMACEUTICALS INC's number of analysts covering the stock is greater than 53.29% of Healthcare stocks.
- NRX PHARMACEUTICALS INC's variance in analysts' estimates is lower than -397.6% of stocks in the small market cap category.
Stocks similar to NRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NCNA, ATNF, and CTXR.
View All Top Stocks by Price Target
What is the outlook for NRXP? Use POWR Ratings for clearer insight into price direction.